Epigenetics Firm Epigentek Focusing on 'Sixth DNA Base'

The Brooklyn-based company has developed technology to identify and quantify 5-hydroxymethylcytosine, which was only identified in mammals a year ago and has been elusive to detection.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories